GlyGenix Therapeutics
Woodbridge
About GlyGenix Therapeutics
GlyGenix Therapeutics, Inc. develops therapeutic products for the treatment of cure metabolic disorders. The company manufactures and delivers genes to cure GSD1a. It has partnerships with National Institutes of Health, Duke University, University of Florida, and Royal Philips Electronics. GlyGenix Therapeutics, Inc. was founded in 2006 and is based in Woodbridge, Connecticut.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Funding stage: Seed
- Last round: Seed (Mar 2014)
- Website: glygenixtherapeutics.com
- Phone: 2033975821
Industries & Categories
Biotechnology, Manufacturing, Residential, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/glygenix-therapeutics-15417 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.